Rescue therapy with oral cyclosporine after use of ustekinumab in ulcerative colitis resistant to multiple treatments

Gastroenterol Hepatol. 2022 Nov;45(9):735-736. doi: 10.1016/j.gastrohep.2021.04.012. Epub 2021 May 31.

[Article in English, Spanish]

Authors

Pablo Ladrón Abia¹, Alejandro Minguez Sabater², Esteban Sáez González², Belén Beltrán Niclós²

Affiliations

¹ Servicio de Gastroenterología y Hepatología del Hospital Universitario y Politécnico la Fe, Valencia, Spain. Electronic address: paul199340@hotmail.com.
² Servicio de Gastroenterología y Hepatología del Hospital Universitario y Politécnico la Fe, Valencia, Spain.

PMID: 34082044
DOI: 10.1016/j.gastrohep.2021.04.012

No abstract available

Publication types

Letter

MeSH terms

Colitis, Ulcerative* / drug therapy
Cyclosporine* / therapeutic use
Humans
Immunosuppressive Agents / adverse effects
Infliximab
Treatment Outcome
Ustekinumab / adverse effects

Substances

Cyclosporine
Ustekinumab
Immunosuppressive Agents
Infliximab